Fortis Malar Hospitals : Q4 2024 Financial Quarterly Report : YoY Sales Down 73.29 %, QoQ Down 68.61 %

The comprehensive analytics outlining the performance and outlook of Fortis Malar Hospitals Limited”s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Today, we’re looking at Fortis Malar Hospitals Limited’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -73.29 %. However, it did see a marginal slip of -68.61 % from the previous quarter. Expenses decreased slightly by -73.06 % quarter-on-quarter, aligning with the annual decline of -74.76 %. Operating profit, while down -32.88 % compared to last year, faced a quarter-on-quarter increase of 144.95 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 5.35 %, but an expansion of 15.08 % sequentially. Other income rose by 38.58 % compared to the last quarter, despite an annual decline of -10.66 %. Interest expenses dropped significantly by -68.25 % from the previous quarter, yet the year-over-year decrease remains at a moderate -71.83 %. Depreciation costs fell by -63.57 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -69.19 %. Profit before tax grew annually by 136.57 % but saw an increase from the preceding quarter by 119.8 %.
Tax expenses as a percentage of profits increased slightly by 230.08 % compared to last year, with a more notable quarter-on-quarter increase of 8.13 %. Net profit rose by 873.25 % year-on-year but experienced a 1451.25 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 873.19 % but a quarterly rise of 1447.66 %. In summary, Fortis Malar Hospitals Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

In reviewing Fortis Malar Hospitals Limited’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -73.29 % year-on-year, although there was a slight dip of -68.61 % from the previous quarter. Expenses decreased by -74.76 % compared to the previous year, with a decrease of -73.06 % quarter-on-quarter. Operating Profit dropped by -32.88 % annually, and saw a 144.95 % increase from the last quarter.
Net Profit showed yearly increase of 873.25 %, and experienced a 1451.25 % increase from the previous quarter. Earnings Per Share (EPS) rose by 873.19 % annually, however rose by 1447.66 % compared to the last quarter. In essence, while Fortis Malar Hospitals Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.